Oaktree Acquisition Corp. III Life Sciences (OACC) Cash from Operations (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Cash from Operations readings, the most recent being 158035.0 for Q1 2026.

  • Quarterly Cash from Operations fell 109.15% to 158035.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 504553.0 through Mar 2026, changed N/A year-over-year, with the annual reading at 422079.0 for FY2025, 370.61% down from the prior year.
  • Cash from Operations hit 158035.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from 143876.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 56518.0 in Q3 2025 and bottomed at 158035.0 in Q1 2026.